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Nursing implications
Trauma Induced Coagulopathy
Paul DeVore, BA, RN, CFRN, EMT-P
Introduction
Signs and symptoms
References
.Problem identification and scope
• “Trauma is the leading cause of death and 
disability between the ages of 5 and 44” (Noel, 
Cashen, Patel, 2013, p. 259).
• Coagulopathy is “the inability of blood to 
coagulate normally” (Katrancha, Gonzalez III, 
2014, p. 54). 
• One quarter of the patients with severe injury 
arrive in the emergency room already suffering 
from acute coagulopathy of trauma (ACOT) 
(Noel, Cashen, Bhavesh, 2013, p. 259).
• Of those suffering severe multisystem trauma 
who make it to the hospital 80% die within 24 
hours (Noel, Cashen, Patel, 2013, p. 259).
The following scenario is played out daily in the 
United States.  An otherwise healthy 30-year-old 
male suffers a traumatic insult from a motor vehicle 
accident.  He presents to the emergency room 
hypotensive, cold, and acidotic with significant blood 
loss.  He is aggressively resuscitated with multiple 
units of normal saline and packed red blood cells 
(PRBC’s), and transferred to the ICU.   There he 
continues to decline succumbing from his injures a 
short 12 hours later from coagulopathy and multiple 
organ failure.  The cause of their death a condition 
known as acute coagulopathy of trauma (ACOT) or 
trauma induced coagulopathy (TIC).  Complicated by 
hypothermia (many times iatrogenic in nature), 
hypoxia, and acidosis from anaerobic metabolism 
patients enter a vicious cycle ending in death.  The 
condition results in depletion, dilution, and 
inactivation of normal clotting factors, and leads to 
the greatest risk from death in the first 24 hours 
following a traumatic incident (Katrancha & 
Gonzalez III, 2014, p. 54).
In over 30 years of treating trauma patients 
this nurse has personally seen the devastating 
effects of multi system blunt and penetrating 
trauma.  With improved prehospital knowledge and 
skill, patients are arriving sooner than ever to 
trauma centers.  Helicopter emergency medical 
service (HEMS), the profession occupied by this 
nurse, adds additional prehospital resources aiding 
in the expeditious transport individuals from remote 
areas to urban trauma centers.   
Historically this nurse found it interesting that TIC 
may have been a contributing factor in the death of 
Jesus 2000 years ago.
Patients who are severely injured appear acutely ill.  This is most 
notable demonstrated by decrease in level of consciousness.  The 
causes of patient presentation are as follows:
• Hypothermia – Hypothermia is many times iatrogenic, caused 
by removing clothing and exposing patients to the elements.  
The addition of ambient temperature fluids used in 
resuscitation further compounds the problem.  Medications and 
anesthetics are also responsible for decrease in body 
temperature (Katrancha, Gonzalez III, 2014, p. 54).  Noel, 
Cashen, and Patel, (2013), provide several interesting facts:
• ISS scores greater than 25 show mortality that increases from 
10% to 100% when body temperature declined from 35 
degrees Celsius to below 32 degrees Celsius (p.263).
• A 10% reduction in coagulation factor activity is seen for every 
1 degree Celsius drop in temperature (p. 263).
• “Hypothermia < 33℃ reduces factor activities below 33%” (p. 
263).
• There is a drop of up to 10 percent in thrombin production for 
each degree below 36℃ (p.263).
• Acidosis – Partially caused by both chloride containing fluids 
and citrate used to preserve blood.  pH levels of less than 7.4 
can reduce the activity of coagulation factors by as much as 
40% (Katrancha, Gonzalez III, 2014, p. 54).  Acidosis will 
contribute to ineffectiveness of administered medications.  Vital 
signs will initially be elevated to compensate for hypoxemia 
and tissue ischemia.  As Compensatory mechanisms fail vital 
signs will deteriorate rapidly and the patient will die.
• Hypoperfusion – This condition leads to an acidotic state with 
the accumulation of the byproducts of metabolism.  This is also 
the primary condition leading to a decrease in mentation.
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Pathophysiology
• Crystalloids, 0.9 normal saline and lactated ringers, the very 
fluids which have long been the gold standard for resuscitation 
are now being investigated as contributors to this deadly 
condition. 
• With a substantial quantity of isotonic solutions diffusion out 
of the vascular space they contribute to interstitial edema, 
acute respiratory distress syndrome (ARDS), and multiple 
organ failure
• Crystalloids are being limited in many institutions to less than 
4 liters in the first 24 hours (Holcomb, Pati, 2013, p. 656). 
• The Department of Defense (DoD) is currently investigating 
the use of three dried plasma preparations (Pusateri, Given, 
Macdonald, Homer, 2016, p. 22). 
• Part of the effectiveness of plasma has been its healing effect 
on the injured glycocalyx of endothelial cells (Holcomb, Pati, 
2103, p. 657).
• The prehospital use of plasma in traumatic hemorrhage study 
(PUPTH) presents a protocol for use of plasma versus saline on 
survival of patients.  The study will look at survival after all 
fluid administration 30 days post event.  This study is again in 
cooperation with the Department of Defense (Reynolds, 
Michael, Cochran, Wegelin, and Spiess, 2015, (pp. 1-8).
• Agents such as tranexamic acid (TXA) are more frequently 
being administered help limit bleeding prior to arrival at a 
trauma center.  By lessening the amount of blood lost, the 
effects of TIC can be ameliorated.
• Cornelius (2017), in a literature review found that TXA, by 
inhibiting fibrinolysis, significantly reduced mortality in 
trauma patients (p. 30).
• United States military use of TXA, prehospital plasma, and 
aeromedical evacuation have resulted in the lowest fatality 
rate on record (Cornelius, 2017, p. 30).
• Four factor prothrombin complex concentrate, which 
combines factors II, VII, IX, and X, has been used successfully 
in reversing major hemorrhage in vitamin K antagonists, like 
coumadin (Untold, Tormey, 2015, p. 1568).
• PCC use in experimental porcine trauma has yielded higher 
fibrinogen, hemoglobin, and platelet counts, with higher mean 
arterial pressure and decreased blood loss (Untold, Tormey, 
2015, pp.1571-1572).
• Of note is that Ward describes swine as hypercoagulable which 
may make the findings with porcine models less relevant to 
humans (Ward, 2013, p. 39).
Death from traumatic incident remains a large problem 
for the American population.  Growing research has 
delineated mechanisms associated with massive hemorrhage 
and hypotension.  The blood which should be protective 
loses this ability due to a process known as coagulopathy of 
trauma.  With optimization of transport, screening, and 
resuscitation practitioners can lessen the already 
devastating effects and help the patient recover as much 
function as possible.  Professional vigilance is needed to stay 
abreast of the latest research providing all patients with 
state of the art care.  This nurse has frequently been 
witnessed to the joy of having a patient who was clinging to 
life come back to say thank you for saving my life.  Few 
rewards are greater for nurses caring for traumatically 
injured patients.
• Soluble vascular endothelial growth factor 1 (sVEGF1)
• Weibel-Palade body degranulation
• Tissue plasminogen activator (tPA)
• Angiopoietin 2 (Ang-2) – endothelial destabilization and 
permeability, increased levels predict poor outcome
• Catecholamine production – favors switch to a hypocoagulable state 
• Angiopoietin 2 (Ang-2) – endothelial destabilization and permeability, increased 
levels predict poor outcome
• Β-catenin – post-transcriptional silencing leads to hyperpermeability
• Heparin like substances – released from damaged glycocalyx  
• Protein C – Activated by plasma membrane bound thrombin-thrombomodulin.  
Active form binds to endothelial cell protein C receptor increasing activation rate by 
20-fold.  Can remain bound to cell or dissociate and combine with protein S 
becoming an anticoagulant.
a. Cleaves bonds in activated cofactors VIII and V that serve to activate X an 
II
b. Promotes fibrinolysis by inhibition of plasminogen activator inhibitor 1
c. Reduction of inflammation decreasing nuclear factor κβ
• Protein S – increase the activity of activated protein C
Hypoperfusion leads to the increased expression of thrombomodulin and activation of 
protein C.  This activation cleaves bonds in both factor VIII and factor V making both 
mediators less active.  Activated protein C (APC) also promotes fibrinolysis and 
inhibition of plasminogen activator inhibitor-1 (PAI-1) (Noel, Cashen, Patel, 2013, p.259).  
Protein C may be protective in states where the blood flow slows, and thus may inhibit 
thrombus formation.  However, when systemic trauma is experienced the normal 
physiology between protein C and PAI-1 becomes pathologic, overwhelming the system 
leading to a state that inhibits clot formation (Ward, 2013, p 38).   Severely injured 
patients were found to have less than 30% of normal coagulation activation.    With 
studies showing abnormalities within 25 minutes from the time of injury (Noel, Cashen, 
Patel, 2013, p. 261).  Low fibrinogen levels are found to be an indicator of mortality at 24 
hours.  Hyperfibrinolysis is another factor of increased mortality.  Fulminant 
hyperfibrinolysis, defined as dissolution of a clot within 60 minutes, had a mortality rate 
of 87.5% (Noel, Cashen, Patel, 2013, p. 262).  Inhibition of PAI-1 by activated protein C 
and tPA release from Weibel-Palade bodies after endothelial activation is the direct cause 
of hyperfibrinolysis (Noel, Cashen, Patel, 2013, p. 262).   International Normalized Ratio 
(INR), was one of the first lab values showing coagulopathies in trauma patients, but is 
too slow to provide the needed information in a more real-time setting (White et. al., 
2014, p. 978).  White et.al., (2014) performed a cluster analysis which groups trauma 
patients according to injury severity score and laboratory parameters.  Their study had 
84 patients which were subsequently divided into three groups. Each group had 
increasing level of traumatic injury.  While all three groups in the study had evidence of 
fibrinolysis only group three (the most severely injured group) had significant platelet 
dysfunction and inflammatory mediators (p. 983).  Compounding the coagulopathy 
caused by trauma is the addition of what Cashen, Noel, and Patel (2013) term 
resuscitation associated coagulopathy (p. 262).  Added to the triad of coagulopathy, 
hypothermia, and acidosis resulting from trauma, is the addition of hemodilution, 
forming what the authors state as the lethal quartet.
Detection of this condition until now has frequently relied on standard lab values 
which may not be available quick enough to guide treatment.  Thromboelastography 
(TEG) can now be used in the emergency room to screen for early indicators of TIC.  TEG 
provides real time information about clot initiation, formation, and stability, and as such 
can help guide resuscitation and mass transfusion protocols (Liou et. al., 2014, p. 94). 
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Figure 1:  Proposed mechanism for the death of 
Jesus  (Bergeron,2012)
Acute coagulopathy of trauma is a multifactorial process 
involving the dysfunction of multiple processes.  Noel, Cashen, and 
Patel (2013) describe the drivers of ACOT as hypoperfusion, 
inflammation, and activation of the neurohumoral system (p.259).  
Platelet activation, endothelial activation, and the presence of 
chemical mediators are essential in the genesis of TIC.  Katrancha
and Gonzalez III, (2014) explain the cell based model of 
coagulation, a model which is supplanting the traditional intrinsic 
and extrinsic cascade models (pp. 54-55).  In this model it is 
platelets, through initiation, amplification, and propagation, that 
lead to normal coagulation.  Platelets were found to be 
“exhausted” in at least 45.5% of trauma patients who were 
admitted to the hospital (Noel, Cashen, Patel, 2013, p. 262). 
Protein C, interacts with this system, and depletion can lead to 
increased fibrinolysis and dysfunctional platelets.   The glycocalyx 
is a thin layer of cells that lines the top of the endothelium.  The 
glycocalyx is negatively charged, and when healthy resists 
adhesion and coagulation (Noel, Cashen, Patel, 2013, p.260). 
Damage causes a release of a variety of factors responsible for the 
effects of ACOT including (Noel, Cashen, Patel, 2013, pp. 260-
262):
• Syndecan-1- endothelial permeability, increasing amount 
leads to protein C depletion and hyperfibrinolysis, increased 
level predicts poor outcomes 
• Vascular endothelial growth factor (VEGF)
Figure 2: Graphic representation of TIC factors 
